Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
The FDA has accused Pinnacle Biologics of creating videos that make it hard for healthcare professionals to “adequately process and comprehend the full indications” for a cancer drug. | The FDA has accused Pinnacle Biologics of creating videos that make it hard for healthcare professionals to “adequately process and comprehend the full indications” for a cancer drug.
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise

The FDA has hit QOL Medical with an untitled letter over emails about Sucraid, accusing the company of creating a misleading…

Pfizer’s complaint about Alnylam’s activities at a cardiology congress has led the PMCPA to chastise the | Pfizer’s complaint…

Following an inspection earlier this year that yielded a Form 483, Indian generics juggernaut Alembic Pharmaceuticals has…

The FDA has paused a controversial policy of releasing letters describing its rationale for rejecting drugs, Fierce Biotech has…

In hopes of challenging Incyte’s topical JAK inhibitor Opzelura, Pfizer is headed to regulators with results from a pair of…

The U.K. | The U.K. pharma marketing watchdog has slammed AGB Pharma for misleadingly implying a lack of fertility considerations…